Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in Eur Radiol

Retrieve available abstracts of 175 articles:
HTML format



Single Articles


    December 2022
  1. YAGHMAI V
    CT-derived extracellular volume to predict post-hepatectomy liver failure: a simple approach to a very complex problem.
    Eur Radiol. 2022;32:8527-8528.
    PubMed    


  2. YU MM, Tang XL, Zhao X, Chen YY, et al
    Plaque progression at coronary CT angiography links non-alcoholic fatty liver disease and cardiovascular events: a prospective single-center study.
    Eur Radiol. 2022;32:8111-8121.
    PubMed     Abstract available


  3. DING WZ, Liu S, Liu F, Cheng Z, et al
    Are all local tumour progressions of HCC related to thermal ablation? A study of the causes and classification of local tumour progression.
    Eur Radiol. 2022;32:8518-8526.
    PubMed     Abstract available


    November 2022
  4. ZHANG L, Li M, Zhu J, Zhang Y, et al
    The value of quantitative MR elastography-based stiffness for assessing the microvascular invasion grade in hepatocellular carcinoma.
    Eur Radiol. 2022 Nov 26. doi: 10.1007/s00330-022-09290.
    PubMed     Abstract available


  5. MARUZZELLI L, D'Amico M, Tuzzolino F, Petridis I, et al
    Clinical outcomes of transjugular intrahepatic portosystemic shunt with PTFE-covered stents after liver transplantation and technical results in split and whole liver graft recipients.
    Eur Radiol. 2022 Nov 23. doi: 10.1007/s00330-022-09259.
    PubMed     Abstract available


  6. CAI Q, Mao Y, Dai S, Gao F, et al
    The growth pattern of liver metastases on MRI predicts early recurrence in patients with colorectal cancer: a multicenter study.
    Eur Radiol. 2022;32:7872-7882.
    PubMed     Abstract available


    September 2022
  7. LIU K, Zheng H, Sui X, Liu B, et al
    Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score-matched study of long-term therapeutic outcomes.
    Eur Radiol. 2022 Sep 17. pii: 10.1007/s00330-022-09135.
    PubMed     Abstract available


  8. XIAO Y, Zheng X, Zhou C, Huang P, et al
    Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction.
    Eur Radiol. 2022 Sep 16. pii: 10.1007/s00330-022-09131.
    PubMed     Abstract available


  9. CHERNYAK V, Tang A, Do RKG, Kamaya A, et al
    Liver imaging: it is time to adopt standardized terminology.
    Eur Radiol. 2022;32:6291-6301.
    PubMed     Abstract available


  10. JOO I, Morrow KW, Raman SS, McWilliams JP, et al
    CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.
    Eur Radiol. 2022;32:6327-6335.
    PubMed     Abstract available


  11. VIETTI VIOLI N, Gnerre J, Law A, Hectors S, et al
    Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology.
    Eur Radiol. 2022;32:6493-6503.
    PubMed     Abstract available


  12. WANG H, Guo Y, Yan B, Zhang Q, et al
    Development and validation of a prediction model based on clinical and CT features for invasiveness of K. pneumoniae liver abscess.
    Eur Radiol. 2022;32:6397-6406.
    PubMed     Abstract available


  13. TAN BG, Tang Z, Ou J, Zhou HY, et al
    A novel model based on liver/spleen volumes and portal vein diameter on MRI to predict variceal bleeding in HBV cirrhosis.
    Eur Radiol. 2022 Sep 1. pii: 10.1007/s00330-022-09107.
    PubMed     Abstract available


    August 2022
  14. ZHANG X, Luo Y, Tsauo J, Zhao H, et al
    Transradial versus transfemoral access without closure device for transarterial chemoembolization in patients with hepatocellular carcinoma: a randomized trial.
    Eur Radiol. 2022 Aug 26. pii: 10.1007/s00330-022-09038.
    PubMed     Abstract available


  15. CHA H, Choi JY, Park YN, Han K, et al
    Comparison of imaging findings of macrotrabecular-massive hepatocellular carcinoma using CT and gadoxetic acid-enhanced MRI.
    Eur Radiol. 2022 Aug 24. pii: 10.1007/s00330-022-09105.
    PubMed     Abstract available


  16. XU Y, Zhang Y, Zheng CZ, Li C, et al
    Thermal ablation versus hepatic resection for colorectal cancer with synchronous liver metastases: a propensity score matching study.
    Eur Radiol. 2022 Aug 24. pii: 10.1007/s00330-022-09080.
    PubMed     Abstract available


  17. SALEH GA, Elmokadem AH, Razek AA, El-Morsy A, et al
    Utility of diffusion tensor imaging in differentiating benign from malignant hepatic focal lesions.
    Eur Radiol. 2022 Aug 18. pii: 10.1007/s00330-022-09091.
    PubMed     Abstract available


  18. CHEN G, Jiao D, Peng S, Chen X, et al
    Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?
    Eur Radiol. 2022 Aug 18. pii: 10.1007/s00330-022-09074.
    PubMed     Abstract available


  19. ZHOU C, Lu X, Wang Y, Qian X, et al
    Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma.
    Eur Radiol. 2022 Aug 17. pii: 10.1007/s00330-022-09065.
    PubMed     Abstract available


  20. NALLET C, Pazart L, Cochet C, Vidal C, et al
    Prenatal quantification of human foetal lung and liver elasticities between 24 and 39 weeks of gestation using 2D shear wave elastography.
    Eur Radiol. 2022;32:5559-5567.
    PubMed     Abstract available


  21. HONG S, Choi SH, Hong SB, Kim SY, et al
    Clinical usefulness of multiple arterial-phase images in gadoxetate disodium-enhanced magnetic resonance imaging: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:5413-5423.
    PubMed     Abstract available


    July 2022
  22. KIM TH, Lee JM, Lee DH, Joo I, et al
    Can "no-touch" radiofrequency ablation for hepatocellular carcinoma improve local tumor control? Systematic review and meta-analysis.
    Eur Radiol. 2022 Jul 30. pii: 10.1007/s00330-022-08991.
    PubMed     Abstract available


  23. OCAL O, Zech CJ, Fabritius MP, Loewe C, et al
    Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression.
    Eur Radiol. 2022 Jul 26. pii: 10.1007/s00330-022-09000.
    PubMed     Abstract available


  24. HUANG JX, Shi CG, Xu YF, Fu J, et al
    The benefit of contrast-enhanced ultrasound in biopsies for focal liver lesions: a retrospective study of 820 cases.
    Eur Radiol. 2022 Jul 26. pii: 10.1007/s00330-022-08988.
    PubMed     Abstract available


  25. CHEN BB, Liang PC, Shih TT, Liu TH, et al
    Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
    Eur Radiol. 2022 Jul 21. pii: 10.1007/s00330-022-08980.
    PubMed     Abstract available


  26. KIM YY, Lee S, Shin J, Son WJ, et al
    Diagnostic performance of CT versus MRI Liver Imaging Reporting and Data System category 5 for hepatocellular carcinoma: a systematic review and meta-analysis of comparative studies.
    Eur Radiol. 2022 Jul 18. pii: 10.1007/s00330-022-08985.
    PubMed     Abstract available


  27. CHOI SJ, Choi SH, Lee DY, Lee JS, et al
    Diagnostic value of [(68) Ga]Ga-DOTA-labeled-somatostatin analogue PET/MRI for detecting liver metastasis in patients with neuroendocrine tumors: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:4628-4637.
    PubMed     Abstract available


  28. ZHU HD, Li X, Ji JS, Huang M, et al
    TACE with dicycloplatin in patients with unresectable hepatocellular carcinoma: a multicenter randomized phase II trial.
    Eur Radiol. 2022 Jul 1. pii: 10.1007/s00330-022-08848.
    PubMed     Abstract available


    June 2022
  29. WANG MQ, Duan F, Guan Y, Yuan B, et al
    Long-term outcomes of transarterial embolization with lipiodol-bleomycin emulsion plus polyvinyl alcohol particles versus the particles alone for large symptomatic focal nodular hyperplasia: a propensity score-matched analysis.
    Eur Radiol. 2022 Jun 28. pii: 10.1007/s00330-022-08972.
    PubMed     Abstract available


  30. DIMOV IP, Tous C, Li N, Barat M, et al
    Assessment of hepatic arterial hemodynamics with 4D flow MRI: in vitro analysis of motion and spatial resolution related error and in vivo feasibility study in 20 volunteers.
    Eur Radiol. 2022 Jun 22. pii: 10.1007/s00330-022-08890.
    PubMed     Abstract available


  31. KENNEDY P, Stocker D, Carbonell G, Said D, et al
    MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension.
    Eur Radiol. 2022 Jun 21. pii: 10.1007/s00330-022-08935.
    PubMed     Abstract available


  32. LIU B, Zeng Q, Huang J, Zhang J, et al
    IVIM using convolutional neural networks predicts microvascular invasion in HCC.
    Eur Radiol. 2022 Jun 17. pii: 10.1007/s00330-022-08927.
    PubMed     Abstract available


  33. HWANG JA, Jeong WK, Kang HJ, Lee ES, et al
    Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
    Eur Radiol. 2022 Jun 16. pii: 10.1007/s00330-022-08900.
    PubMed     Abstract available


  34. JIAO CY, Zhang H, Ji GW, Xu Q, et al
    CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
    Eur Radiol. 2022 Jun 16. pii: 10.1007/s00330-022-08914.
    PubMed     Abstract available


  35. PENG Y, Shen H, Tang H, Huang Y, et al
    Nomogram based on CT-derived extracellular volume for the prediction of post-hepatectomy liver failure in patients with resectable hepatocellular carcinoma.
    Eur Radiol. 2022 Jun 9. pii: 10.1007/s00330-022-08917.
    PubMed     Abstract available


  36. DE COBELLI F, Calandri M, Della Corte A, Sirovich R, et al
    Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
    Eur Radiol. 2022;32:4147-4159.
    PubMed     Abstract available


  37. ZHANG K, Xie SS, Li WC, Ye ZX, et al
    Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators.
    Eur Radiol. 2022;32:4186-4197.
    PubMed     Abstract available


    May 2022
  38. HUANG Z, Zhou P, Li S, Li K, et al
    Evaluation of contrast-enhanced ultrasound LI-RADS version 2017: application on 271 liver nodules in individuals with non-alcoholic steatohepatitis.
    Eur Radiol. 2022 May 31. pii: 10.1007/s00330-022-08872.
    PubMed     Abstract available


  39. MENG D, Liang C, Zheng Y, Wang X, et al
    The value of gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase for predicting post-hepatectomy liver failure in HCC patients.
    Eur Radiol. 2022 May 31. pii: 10.1007/s00330-022-08874.
    PubMed     Abstract available


  40. TAGO K, Tsukada J, Sudo N, Shibutani K, et al
    Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma.
    Eur Radiol. 2022 May 20. pii: 10.1007/s00330-022-08852.
    PubMed     Abstract available


  41. PAN J, Li W, Gu L, Liu C, et al
    Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis.
    Eur Radiol. 2022 May 17. pii: 10.1007/s00330-022-08826.
    PubMed     Abstract available


  42. WEI H, Jiang H, Qin Y, Wu Y, et al
    Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.
    Eur Radiol. 2022 May 13. pii: 10.1007/s00330-022-08811.
    PubMed     Abstract available


  43. HEO S, Kim DW, Choi SH, Kim SW, et al
    Diagnostic performance of liver fibrosis assessment by quantification of liver surface nodularity on computed tomography and magnetic resonance imaging: systematic review and meta-analysis.
    Eur Radiol. 2022;32:3377-3387.
    PubMed     Abstract available


  44. SHIN J, Lee S, Hwang JA, Lee JE, et al
    MRI-diagnosis of category LR-M observations in the Liver Imaging Reporting and Data System v2018: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:3319-3326.
    PubMed     Abstract available


  45. TANG A, Dzyubak B, Yin M, Schlein A, et al
    MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T.
    Eur Radiol. 2022;32:2937-2948.
    PubMed     Abstract available


  46. PARK S, Yoon JH, Joo I, Yu MH, et al
    Image quality in liver CT: low-dose deep learning vs standard-dose model-based iterative reconstructions.
    Eur Radiol. 2022;32:2865-2874.
    PubMed     Abstract available


  47. GHADIMI M, Birnbaum J, Kamel IR, Sirlin CB, et al
    What proportion of LI-RADS 5 observations reported in clinical practice do not meet LI-RADS 5 criteria?
    Eur Radiol. 2022;32:3327-3333.
    PubMed     Abstract available


    April 2022
  48. QIU Z, Wang G, Yan H, Qi H, et al
    TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension.
    Eur Radiol. 2022 Apr 20. pii: 10.1007/s00330-022-08705.
    PubMed     Abstract available


  49. ZHANG W, Wang J, Linghu R, Chen X, et al
    Correction to: Comparison between spleen and liver stiffness measurements by sound touch elastography for diagnosing cirrhosis at different aminotransferase levels: a prospective multicenter study.
    Eur Radiol. 2022 Apr 12. pii: 10.1007/s00330-022-08727.
    PubMed    


  50. MULLER L, Kloeckner R, Mahringer-Kunz A, Stoehr F, et al
    Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC.
    Eur Radiol. 2022 Apr 8. pii: 10.1007/s00330-022-08737.
    PubMed     Abstract available


  51. WANG X, Tan Y, Liu D, Shen H, et al
    Chemotherapy-associated steatohepatitis was concomitant with epicardial adipose tissue volume increasing in breast cancer patients who received neoadjuvant chemotherapy.
    Eur Radiol. 2022 Apr 8. pii: 10.1007/s00330-022-08581.
    PubMed     Abstract available


  52. XIA D, Wang Q, Bai W, Wang E, et al
    Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization.
    Eur Radiol. 2022 Apr 6. pii: 10.1007/s00330-022-08716.
    PubMed     Abstract available


  53. LEE T, Lee JM, Yoon JH, Joo I, et al
    Deep learning-based image reconstruction of 40-keV virtual monoenergetic images of dual-energy CT for the assessment of hypoenhancing hepatic metastasis.
    Eur Radiol. 2022 Apr 5. pii: 10.1007/s00330-022-08728.
    PubMed     Abstract available


  54. ZHANG YN, Fowler KJ, Boehringer AS, Montes V, et al
    Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease.
    Eur Radiol. 2022;32:2457-2469.
    PubMed     Abstract available


  55. DOEMEL LA, Santana JG, Savic LJ, Gaupp FML, et al
    Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model.
    Eur Radiol. 2022;32:2437-2447.
    PubMed     Abstract available


  56. BENOIT C, Rodrigues A, Calderaro J, Charpy C, et al
    Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors.
    Eur Radiol. 2022;32:2481-2491.
    PubMed     Abstract available


    March 2022
  57. YOUN SY, Kim B, Kim DH, Choi HJ, et al
    Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma.
    Eur Radiol. 2022 Mar 29. pii: 10.1007/s00330-022-08720.
    PubMed     Abstract available


  58. WANG Y, Zhu GQ, Zhou CW, Li N, et al
    Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors.
    Eur Radiol. 2022 Mar 22. pii: 10.1007/s00330-022-08691.
    PubMed     Abstract available


  59. SHENG R, Huang X, Jin K, Gao S, et al
    Contrast-enhanced MRI could predict response of systemic therapy in advanced intrahepatic cholangiocarcinoma.
    Eur Radiol. 2022 Mar 17. pii: 10.1007/s00330-022-08679.
    PubMed     Abstract available


  60. LUO N, Huang X, Ji Y, Jin G, et al
    A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection.
    Eur Radiol. 2022 Mar 16. pii: 10.1007/s00330-022-08656.
    PubMed     Abstract available


  61. PAN J, Tao Y, Chi X, Yang L, et al
    Do transition and hepatobiliary phase hypointensity improve LI-RADS categorization as an alternative washout: a systematic review and meta-analysis.
    Eur Radiol. 2022 Mar 10. pii: 10.1007/s00330-022-08665.
    PubMed     Abstract available


  62. YOON JK, Choi JY, Rhee H, Park YN, et al
    MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification.
    Eur Radiol. 2022 Mar 8. pii: 10.1007/s00330-022-08643.
    PubMed     Abstract available


  63. KONG J, Gao R, Wu S, Shi Y, et al
    Correction to: Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.
    Eur Radiol. 2022 Mar 3. pii: 10.1007/s00330-022-08634.
    PubMed    


  64. COSTANTINO A, Piagnani A, Nandi N, Sciola V, et al
    Reproducibility and diagnostic accuracy of pocket-sized ultrasound devices in ruling out compensated cirrhosis of mixed etiology.
    Eur Radiol. 2022 Mar 3. pii: 10.1007/s00330-022-08572.
    PubMed     Abstract available


  65. YAN Y, Xing X, Wang X, Yang L, et al
    Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.
    Eur Radiol. 2022;32:2078-2088.
    PubMed     Abstract available


  66. BOS D, Yu S, Luong J, Chu P, et al
    Diagnostic reference levels and median doses for common clinical indications of CT: findings from an international registry.
    Eur Radiol. 2022;32:1971-1982.
    PubMed     Abstract available


  67. WANG Q, Wang A, Sparrelid E, Zhang J, et al
    Predictive value of gadoxetic acid-enhanced MRI for posthepatectomy liver failure: a systematic review.
    Eur Radiol. 2022;32:1792-1803.
    PubMed     Abstract available


  68. CANNELLA R, Vernuccio F, Antonucci M, Gagliano DS, et al
    LI-RADS ancillary features favoring benignity: is there a role in LR-5 observations?
    Eur Radiol. 2022;32:1804-1812.
    PubMed     Abstract available


  69. DIOGUARDI BURGIO M, Sartoris R, Beaufrere A, Gregory J, et al
    Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD.
    Eur Radiol. 2022;32:1781-1791.
    PubMed     Abstract available


  70. SCHATTENBERG JM, Emrich T
    Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic?
    Eur Radiol. 2022;32:1757-1759.
    PubMed    


  71. LUDEMANN W, Kahn J, Pustelnik D, Hardt J, et al
    Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection.
    Eur Radiol. 2022 Mar 1. pii: 10.1007/s00330-022-08585.
    PubMed     Abstract available


    February 2022
  72. ZHANG W, Wang J, Linghu R, Chen X, et al
    Comparison between spleen and liver stiffness measurements by sound touch elastography for diagnosing cirrhosis at different aminotransferase levels: a prospective multicenter study.
    Eur Radiol. 2022 Feb 28. pii: 10.1007/s00330-022-08569.
    PubMed     Abstract available


  73. PARK HJ, Lee TY, Kim SY, Kim MJ, et al
    Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI: long-term follow-up in a surveillance cohort.
    Eur Radiol. 2022 Feb 28. pii: 10.1007/s00330-022-08623.
    PubMed     Abstract available


  74. LIU Y, Tan HY, Zhang XG, Zhen YH, et al
    Prediction of high-risk esophageal varices in patients with chronic liver disease with point and 2D shear wave elastography: a systematic review and meta-analysis.
    Eur Radiol. 2022 Feb 15. pii: 10.1007/s00330-022-08601.
    PubMed     Abstract available


  75. LI M, Yin Z, Hu B, Guo N, et al
    MR Elastography-Based Shear Strain Mapping for Assessment of Microvascular Invasion in Hepatocellular Carcinoma.
    Eur Radiol. 2022 Feb 11. pii: 10.1007/s00330-022-08578.
    PubMed     Abstract available


  76. SERBANESCU-KELE APOR DE ZALAN , Ruiter SJS, van den Berg AP, Pennings JP, et al
    Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation.
    Eur Radiol. 2022 Feb 8. pii: 10.1007/s00330-021-08515.
    PubMed     Abstract available


  77. ZHOU Y, Zhou G, Zhang J, Xu C, et al
    DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
    Eur Radiol. 2022 Feb 7. pii: 10.1007/s00330-022-08548.
    PubMed     Abstract available


  78. XIONG J, Luo J, Bian J, Wu J, et al
    Overall diagnostic accuracy of different MR imaging sequences for detection of dysplastic nodules: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:1285-1296.
    PubMed     Abstract available


  79. LI X, Qi Z, Du H, Geng Z, et al
    Deep convolutional neural network for preoperative prediction of microvascular invasion and clinical outcomes in patients with HCCs.
    Eur Radiol. 2022;32:771-782.
    PubMed     Abstract available


  80. MIN JH, Kim JM, Kim YK, Kim H, et al
    A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions.
    Eur Radiol. 2022;32:912-922.
    PubMed     Abstract available


  81. SUN C, Zhang X, Chen X, Zhu T, et al
    Single-direction diffusion-weighted imaging may be a simple complementary sequence for evaluating fetal corpus callosum.
    Eur Radiol. 2022;32:1135-1143.
    PubMed     Abstract available


    January 2022
  82. ZHENG H, Liu K, Yang Y, Liu B, et al
    Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Eur Radiol. 2022 Jan 29. pii: 10.1007/s00330-022-08537.
    PubMed     Abstract available


  83. KONG J, Gao R, Wu S, Shi Y, et al
    Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.
    Eur Radiol. 2022 Jan 29. pii: 10.1007/s00330-021-08425.
    PubMed     Abstract available


  84. KELAHAN LC, Kim D, Soliman M, Avery RJ, et al
    Role of hepatic metastatic lesion size on inter-reader reproducibility of CT-based radiomics features.
    Eur Radiol. 2022 Jan 26. pii: 10.1007/s00330-021-08526.
    PubMed     Abstract available


  85. DONG SY, Wang WT, Chen XS, Yang YT, et al
    Microvascular invasion of small hepatocellular carcinoma can be preoperatively predicted by the 3D quantification of MRI.
    Eur Radiol. 2022 Jan 25. pii: 10.1007/s00330-021-08495.
    PubMed     Abstract available


  86. YOUNG S, Chen T, Flanagan S, Golzarian J, et al
    Realized tumor to normal ratios in hepatocellular carcinoma patients undergoing transarterial radioembolization: a retrospective evaluation.
    Eur Radiol. 2022 Jan 15. pii: 10.1007/s00330-021-08501.
    PubMed     Abstract available


  87. SUN SH, Eche T, Dorczynski C, Otal P, et al
    Predicting death or recurrence of portal hypertension symptoms after TIPS procedures.
    Eur Radiol. 2022 Jan 11. pii: 10.1007/s00330-021-08437.
    PubMed     Abstract available


  88. LIU C, Shen Z, Ma H, Wang X, et al
    Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure.
    Eur Radiol. 2022 Jan 6. pii: 10.1007/s00330-021-08440.
    PubMed     Abstract available


  89. WACKENTHALER A, Moliere S, Artzner T, Michard B, et al
    Pre-operative CT scan helps predict outcome after liver transplantation for acute-on-chronic grade 3 liver failure.
    Eur Radiol. 2022;32:12-21.
    PubMed     Abstract available


  90. JEON SK, Joo I, Bae JS, Park SJ, et al
    LI-RADS v2018: how to appropriately use ancillary features in category adjustment from intermediate probability of malignancy (LR-3) to probably HCC (LR-4) on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2022;32:46-55.
    PubMed     Abstract available


    December 2021
  91. AUER TA, Fehrenbach U, Grieser C, Penzkofer T, et al
    Correction to: Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
    Eur Radiol. 2021 Dec 5. pii: 10.1007/s00330-021-08386.
    PubMed    


  92. GHANI MA, Fereydooni A, Chen E, Letzen B, et al
    Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.
    Eur Radiol. 2021;31:8858-8867.
    PubMed     Abstract available


  93. LI M, Yang H, Liu Y, Zhang L, et al
    Comparison of the diagnostic performance of 2D and 3D MR elastography in staging liver fibrosis.
    Eur Radiol. 2021;31:9468-9478.
    PubMed     Abstract available


  94. YIN Y, Yakar D, Dierckx RAJO, Mouridsen KB, et al
    Liver fibrosis staging by deep learning: a visual-based explanation of diagnostic decisions of the model.
    Eur Radiol. 2021;31:9620-9627.
    PubMed     Abstract available


  95. SCHEGERER AA, Frija G, Paulo G, Jaschke W, et al
    Radiation dose and diagnostic reference levels for four interventional radiology procedures: results of the prospective European multicenter survey EUCLID.
    Eur Radiol. 2021;31:9346-9360.
    PubMed     Abstract available


    November 2021
  96. GRIESER C
    Editorial comment: advances in the evaluation of liver imaging and function with gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:8374-8375.
    PubMed    


  97. MARKICH R, Palussiere J, Catena V, Cazayus M, et al
    Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation.
    Eur Radiol. 2021;31:8302-8314.
    PubMed     Abstract available


  98. QU Y, Middleton MS, Loomba R, Glaser KJ, et al
    Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.
    Eur Radiol. 2021;31:8408-8419.
    PubMed     Abstract available


  99. FAN W, Guo J, Zhu B, Wang S, et al
    Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS.
    Eur Radiol. 2021;31:8291-8301.
    PubMed     Abstract available


  100. HAM JH, Yu JS, Choi JM, Cho ES, et al
    Corona enhancement can substitute enhancing capsule in the imaging diagnosis of small (
    Eur Radiol. 2021;31:8628-8637.
    PubMed     Abstract available


  101. LU X, Zhou H, Wang K, Jin J, et al
    Comparing radiomics models with different inputs for accurate diagnosis of significant fibrosis in chronic liver disease.
    Eur Radiol. 2021;31:8743-8754.
    PubMed     Abstract available


    October 2021
  102. YANG J, Huang JY, Chen X, Ling WW, et al
    Correction to: Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
    Eur Radiol. 2021 Oct 14. pii: 10.1007/s00330-021-08256.
    PubMed    


  103. BARGELLINI I, Lorenzoni V, Lorenzoni G, Scalise P, et al
    Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naive patients: a propensity score matching analysis.
    Eur Radiol. 2021;31:7512-7522.
    PubMed     Abstract available


  104. KONG C, Zhao Z, Chen W, Lv X, et al
    Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
    Eur Radiol. 2021;31:7500-7511.
    PubMed     Abstract available


  105. RONG D, Liu W, Kuang S, Xie S, et al
    Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI.
    Eur Radiol. 2021;31:7584-7593.
    PubMed     Abstract available


  106. GUPTA P, Bansal A, Das GC, Kumar-M P, et al
    Diagnostic accuracy of Liver Imaging Reporting and Data System locoregional treatment response criteria: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:7725-7733.
    PubMed     Abstract available


    September 2021
  107. CARBONELL G, Kennedy P, Bane O, Kirmani A, et al
    Precision of MRI radiomics features in the liver and hepatocellular carcinoma.
    Eur Radiol. 2021 Sep 26. pii: 10.1007/s00330-021-08282.
    PubMed     Abstract available


  108. JANG JK, Kim SY, Yoo IW, Cho YB, et al
    Diagnostic performance of ultrasound attenuation imaging for assessing low-grade hepatic steatosis.
    Eur Radiol. 2021 Sep 21. pii: 10.1007/s00330-021-08269.
    PubMed     Abstract available


  109. YU Y, Fan Y, Wang X, Zhu M, et al
    Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.
    Eur Radiol. 2021 Sep 4. pii: 10.1007/s00330-021-08250.
    PubMed     Abstract available


  110. FRONDA M, Doriguzzi Breatta A, Gatti M, Calandri M, et al
    Quantitative assessment of HCC wash-out on CT is a predictor of early complete response to TACE.
    Eur Radiol. 2021;31:6578-6588.
    PubMed     Abstract available


  111. KANG JH, Choi SH, Lee JS, Kim KW, et al
    Inter-reader reliability of CT Liver Imaging Reporting and Data System according to imaging analysis methodology: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:6856-6867.
    PubMed     Abstract available


  112. LI W, Li L, Zhuang BW, Ruan SM, et al
    Inter-reader agreement of CEUS LI-RADS among radiologists with different levels of experience.
    Eur Radiol. 2021;31:6758-6767.
    PubMed     Abstract available


  113. WANG G, Xie X, Chen H, Zhong Z, et al
    Development of a pediatric liver CEUS criterion to classify benign and malignant liver lesions in pediatric patients: a pilot study.
    Eur Radiol. 2021;31:6747-6757.
    PubMed     Abstract available


  114. GUPTA P, Maralakunte M, Sagar S, Kumar-M P, et al
    Efficacy and safety of irreversible electroporation for malignant liver tumors: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:6511-6521.
    PubMed     Abstract available


  115. CANNELLA R, Fraum TJ, Ludwig DR, Borhani AA, et al
    Targetoid appearance on T2-weighted imaging and signs of tumor vascular involvement: diagnostic value for differentiating HCC from other primary liver carcinomas.
    Eur Radiol. 2021;31:6868-6878.
    PubMed     Abstract available


  116. LAIMER G, Jaschke N, Schullian P, Putzer D, et al
    Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
    Eur Radiol. 2021;31:6489-6499.
    PubMed     Abstract available


    August 2021
  117. OCAL O, Peynircioglu B, Loewe C, van Delden O, et al
    Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial.
    Eur Radiol. 2021 Aug 31. pii: 10.1007/s00330-021-08218.
    PubMed     Abstract available


  118. CHEN J, Allen AM, Therneau TM, Chen J, et al
    Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis.
    Eur Radiol. 2021 Aug 25. pii: 10.1007/s00330-021-08225.
    PubMed     Abstract available


  119. KIM GH, Kim PH, Kim JH, Kim PN, et al
    Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
    Eur Radiol. 2021 Aug 4. pii: 10.1007/s00330-021-08216.
    PubMed     Abstract available


  120. NAGAYAMA Y, Kato Y, Inoue T, Nakaura T, et al
    Liver fibrosis assessment with multiphasic dual-energy CT: diagnostic performance of iodine uptake parameters.
    Eur Radiol. 2021;31:5779-5790.
    PubMed     Abstract available


  121. YOH T, Perrot A, Beaufrere A, Hobeika C, et al
    Liver surface nodularity: a novel predictor of post-hepatectomy liver failure in patients with colorectal liver metastases following chemotherapy.
    Eur Radiol. 2021;31:5830-5839.
    PubMed     Abstract available


  122. KOH DM, Ba-Ssalamah A, Brancatelli G, Fananapazir G, et al
    Consensus report from the 9(th) International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging.
    Eur Radiol. 2021;31:5615-5628.
    PubMed     Abstract available


  123. CHENG MQ, Hu HT, Huang H, Pan JM, et al
    Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade.
    Eur Radiol. 2021;31:5680-5688.
    PubMed     Abstract available


  124. ALI A, Ahle M, Bjornsson B, Sandstrom P, et al
    Portal vein embolization with N-butyl cyanoacrylate glue is superior to other materials: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:5464-5478.
    PubMed     Abstract available


  125. LEE DH, Lee ES, Bae JS, Lee JY, et al
    2D shear wave elastography is better than transient elastography in predicting post-hepatectomy complication after resection.
    Eur Radiol. 2021;31:5802-5811.
    PubMed     Abstract available


  126. HABIBZADEH F, Habibzadeh P, Shakibafard A, Saidi F, et al
    Predicting the outcome of asymptomatic univesicular liver hydatids: diagnostic accuracy of unenhanced CT.
    Eur Radiol. 2021;31:5812-5817.
    PubMed     Abstract available


  127. LIU LH, Zhou GF, Lv H, Wang ZC, et al
    Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI.
    Eur Radiol. 2021;31:5640-5649.
    PubMed     Abstract available


    July 2021
  128. ZHOU C, Wang Y, Ma L, Qian X, et al
    Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
    Eur Radiol. 2021 Jul 19. pii: 10.1007/s00330-021-08188.
    PubMed     Abstract available


  129. NAJAFI A, de Baere T, Purenne E, Bayar A, et al
    Risk factors for local tumor progression after RFA of pulmonary metastases: a matched case-control study.
    Eur Radiol. 2021;31:5361-5369.
    PubMed     Abstract available


  130. HASENSTAB K, Cunha GM, Ichikawa S, Dehkordy SF, et al
    CNN color-coded difference maps accurately display longitudinal changes in liver MRI-PDFF.
    Eur Radiol. 2021;31:5041-5049.
    PubMed     Abstract available


  131. HUANG M, Shen S, Cai H, Peng Z, et al
    Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC.
    Eur Radiol. 2021;31:4720-4730.
    PubMed     Abstract available


  132. MAO B, Ma J, Duan S, Xia Y, et al
    Preoperative classification of primary and metastatic liver cancer via machine learning-based ultrasound radiomics.
    Eur Radiol. 2021;31:4576-4586.
    PubMed     Abstract available


  133. PARK JH, Seo N, Chung YE, Kim SU, et al
    Noninvasive evaluation of liver fibrosis: comparison of the stretched exponential diffusion-weighted model to other diffusion-weighted MRI models and transient elastography.
    Eur Radiol. 2021;31:4813-4823.
    PubMed     Abstract available


  134. GUPTA P, Maralakunte M, Kumar-M P, Chandel K, et al
    Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
    Eur Radiol. 2021;31:5400-5408.
    PubMed     Abstract available


  135. YOUN SY, Kim DH, Choi SH, Kim B, et al
    Diagnostic performance of Liver Imaging Reporting and Data System treatment response algorithm: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:4785-4793.
    PubMed     Abstract available


    June 2021
  136. YOON JH, Lee JM, Yu MH, Hur BY, et al
    Simultaneous evaluation of perfusion and morphology using GRASP MRI in hepatic fibrosis.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-08087.
    PubMed     Abstract available


  137. VICENTIN I, Mosconi C, Garanzini E, Sposito C, et al
    Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinoma.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-08088.
    PubMed     Abstract available


  138. OBMANN VC, Berzigotti A, Catucci D, Ebner L, et al
    T1 mapping of the liver and the spleen in patients with liver fibrosis-does normalization to the blood pool increase the predictive value?
    Eur Radiol. 2021;31:4308-4318.
    PubMed     Abstract available


  139. JIANG H, Song B, Qin Y, Chen J, et al
    Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
    Eur Radiol. 2021;31:3638-3648.
    PubMed     Abstract available


  140. MIN JH, Kim SH, Hwang JA, Hyun SH, et al
    Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
    Eur Radiol. 2021;31:3649-3660.
    PubMed     Abstract available


  141. HECTORS SJ, Kennedy P, Huang KH, Stocker D, et al
    Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:3805-3814.
    PubMed     Abstract available


    May 2021
  142. STOCKER D, Hectors S, Bane O, Vietti-Violi N, et al
    Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
    Eur Radiol. 2021 May 27. pii: 10.1007/s00330-021-08068.
    PubMed     Abstract available


  143. CHOI SH, Jeon SK, Lee SS, Lee JM, et al
    Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI.
    Eur Radiol. 2021 May 26. pii: 10.1007/s00330-021-07984.
    PubMed     Abstract available


  144. KIM PH, Hwang J, Yoon HM, Shin HJ, et al
    Outcome of staging chest CT and identification of factors associated with lung metastasis in children with hepatoblastoma.
    Eur Radiol. 2021 May 25. pii: 10.1007/s00330-021-08047.
    PubMed     Abstract available


  145. NOWAK S, Mesropyan N, Faron A, Block W, et al
    Detection of liver cirrhosis in standard T2-weighted MRI using deep transfer learning.
    Eur Radiol. 2021 May 11. pii: 10.1007/s00330-021-07858.
    PubMed     Abstract available


  146. BAE H, Lee H, Kim S, Han K, et al
    Radiomics analysis of contrast-enhanced CT for classification of hepatic focal lesions in colorectal cancer patients: its limitations compared to radiologists.
    Eur Radiol. 2021 May 10. pii: 10.1007/s00330-021-07877.
    PubMed     Abstract available


  147. REIMER RP, Grosse Hokamp N, Fehrmann Efferoth A, Krauskopf A, et al
    Virtual monoenergetic images from spectral detector computed tomography facilitate washout assessment in arterially hyper-enhancing liver lesions.
    Eur Radiol. 2021;31:3468-3477.
    PubMed     Abstract available


  148. SCHULLIAN P, Johnston E, Laimer G, Putzer D, et al
    Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
    Eur Radiol. 2021;31:3042-3052.
    PubMed     Abstract available


  149. SAVIC LJ, Chapiro J, Funai E, Bousabarah K, et al
    Prospective study of Lipiodol distribution as an imaging marker for doxorubicin pharmacokinetics during conventional transarterial chemoembolization of liver malignancies.
    Eur Radiol. 2021;31:3002-3014.
    PubMed     Abstract available


    April 2021
  150. LIN CC, Lui KW, Chen WT, Hsieh YC, et al
    Switching monopolar radiofrequency ablation improves long-term outcomes of medium-sized hepatocellular carcinoma.
    Eur Radiol. 2021 Apr 25. pii: 10.1007/s00330-021-07729.
    PubMed     Abstract available


  151. PARK HJ, Park B, Park SY, Choi SH, et al
    Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
    Eur Radiol. 2021 Apr 23. pii: 10.1007/s00330-021-07926.
    PubMed     Abstract available


  152. LEE HJ, Hong SB, Lee NK, Kim S, et al
    Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS.
    Eur Radiol. 2021 Apr 21. pii: 10.1007/s00330-021-07955.
    PubMed     Abstract available


  153. RYU H, Shin SY, Lee JY, Lee KM, et al
    Joint segmentation and classification of hepatic lesions in ultrasound images using deep learning.
    Eur Radiol. 2021 Apr 21. pii: 10.1007/s00330-021-07850.
    PubMed     Abstract available


  154. TANG M, Zhou Q, Huang M, Sun K, et al
    Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021 Apr 20. pii: 10.1007/s00330-021-07941.
    PubMed     Abstract available


  155. CUNHA GM, Hasenstab KA, Delgado T, Ichikawa S, et al
    Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma.
    Eur Radiol. 2021 Apr 19. pii: 10.1007/s00330-021-07924.
    PubMed     Abstract available


  156. CHEN J, Xia C, Duan T, Cao L, et al
    Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07898.
    PubMed     Abstract available


  157. HWANG JA, Min JH, Kang TW, Jeong WK, et al
    Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07897.
    PubMed     Abstract available


  158. STROBEL D, Jung EM, Ziesch M, Praktiknjo M, et al
    Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS(R)/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07872.
    PubMed     Abstract available


  159. GHORRA C, Pommier R, Piveteau A, Rubbia-Brandt L, et al
    The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases.
    Eur Radiol. 2021;31:2451-2460.
    PubMed     Abstract available


  160. DEFREYNE L
    Interventional radiology for liver diseases.
    Eur Radiol. 2021;31:2227-2230.
    PubMed    


  161. KIM DH, Choi SH, Park SH, Kim KW, et al
    The Liver Imaging Reporting and Data System tumor-in-vein category: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:2497-2506.
    PubMed     Abstract available


  162. VOGL TJ, Marko C, Langenbach MC, Naguib NNN, et al
    Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial.
    Eur Radiol. 2021;31:2242-2251.
    PubMed     Abstract available


    March 2021
  163. RONOT M, Ferraioli G, Muller HP, Friedrich-Rust M, et al
    Comparison of liver stiffness measurements by a 2D-shear wave technique and transient elastography: results from a European prospective multi-centre study.
    Eur Radiol. 2021;31:1578-1587.
    PubMed     Abstract available


  164. SARWAR A, Kudla A, Weinstein JL, Ali A, et al
    Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.
    Eur Radiol. 2021;31:1316-1324.
    PubMed     Abstract available


  165. XU X, Zhu H, Li R, Lin H, et al
    Whole-liver histogram and texture analysis on T1 maps improves the risk stratification of advanced fibrosis in NAFLD.
    Eur Radiol. 2021;31:1748-1759.
    PubMed     Abstract available


  166. SHAGHAGHI M, Aliyari Ghasabeh M, Ameli S, Ghadimi M, et al
    Post-TACE changes in ADC histogram predict overall and transplant-free survival in patients with well-defined HCC: a retrospective cohort with up to 10 years follow-up.
    Eur Radiol. 2021;31:1378-1390.
    PubMed     Abstract available


  167. LEFEBVRE T, Hebert M, Bilodeau L, Sebastiani G, et al
    Intravoxel incoherent motion diffusion-weighted MRI for the characterization of inflammation in chronic liver disease.
    Eur Radiol. 2021;31:1347-1358.
    PubMed     Abstract available


  168. COLAGRANDE S, Calistri L, Campani C, Dragoni G, et al
    CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib.
    Eur Radiol. 2021;31:1608-1619.
    PubMed     Abstract available


    February 2021
  169. LEE S, Kim SS, Bae H, Shin J, et al
    Application of Liver Imaging Reporting and Data System version 2018 ancillary features to upgrade from LR-4 to LR-5 on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:855-863.
    PubMed     Abstract available


  170. DING J, Long L, Zhang X, Chen C, et al
    Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
    Eur Radiol. 2021;31:847-854.
    PubMed     Abstract available


    January 2021
  171. ALSHEHRI E, Lam CZ, Kamath BM, Chavhan GB, et al
    Abdominal lymphatic system visibility, morphology, and abnormalities in children as seen on routine MCRP and its association with immune-mediated diseases.
    Eur Radiol. 2021;31:292-301.
    PubMed     Abstract available


  172. GU K, Jeon TY, Yoo SY, Kim JH, et al
    Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors.
    Eur Radiol. 2021;31:283-291.
    PubMed     Abstract available


  173. SEO N, Jeong HK, Choi JY, Park MS, et al
    Liver MRI with amide proton transfer imaging: feasibility and accuracy for the characterization of focal liver lesions.
    Eur Radiol. 2021;31:222-231.
    PubMed     Abstract available


  174. STEINKOHL F, Barbieri F, Senoner T, Strobl S, et al
    Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study.
    Eur Radiol. 2021;31:494-503.
    PubMed     Abstract available


  175. TSAUO J, Noh SY, Shin JH, Gwon DI, et al
    Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with portal vein thrombosis: a multicenter study.
    Eur Radiol. 2021;31:559-566.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: